Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: OLE1 inhibitor resistant mutants

PROVIDER: PRJNA496936 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR8062502.fastq.gz	Fastqsanger.gz
	SRR8062503.fastq.gz	Fastqsanger.gz
	SRR8062504.fastq.gz	Fastqsanger.gz
	SRR8062505.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Mycobacterium tuberculosis strain:H37Rv

Project description:M. tuberculosis resistant mutants to BioAMS, a BirA inhibitor

| PRJNA412260 | ENA

Comparison of CX-4945 and SCG-CK2-1 as Inhibitors of CSNK2 using Quantitative Phosphoproteomics: Triple SILAC in combination with Inhibitor-Resistant CSNK2

Project description:Specificity is a limiting factor when using small-molecule inhibitors to study protein kinase signalling. Since inhibitor-resistant kinase mutants (i.e., drug-resistant alleles) remain active in the presence of inhibitor, they facilitate validation of on-target effects. By combining an inhibitor-resistant kinase mutant with mass spectrometry-based phosphoproteomics, we previously devised a systematic strategy for reliable identification and validation of CSNK2 substrates. In this study, we use the same strategy to evaluate the selectivity of CX-4945, a clinical stage CSNK2 inhibitor, and SGC-CK2-1, a chemical probe selectively targeting CSNK2. Human osteosarcoma (U2OS) cells expressing exogenous wild-type CSNK2A1 (WT) or an inhibitor-resistant triple mutant (TM, V66A/H160D/I174A) were treated with CX-4945 or SGC-CK2-1 prior to analysis using triple SILAC (phospho)proteomics. The minority of phosphosites, 15% at 4 hours and 5% at 24 hours, that were significantly downregulated in response to CX-4945 treatment were determined to be CSNK2A1-dependent. By comparison, the majority of phosphosites, >55% at both 4 and 24 hours, that were significantly downregulated in response to SGC-CK2-1 were identified as CSNK2A1-dependent. This indicates that SGC-CK2-1 exhibits dramatically greater selectivity towards CSNK2A1 than CX-4945. Notably, utilization of SGC-CK2-1 in cells expressing TM-CSNK2A1 enabled the identification of 330 CSNK2A1-dependent phosphosites. Overall, this study highlights the utility of exploiting highly selective chemical probes together with inhibitor-resistant kinase mutants to identify bona fide kinase substrates.

2023-08-14 | PXD038050 | Pride

Project description:canavanine-resistant mutants

| PRJNA1062442 | ENA

Project description:Cystobactamid resistant mutants

| PRJNA1022506 | ENA

E-GEOD-47346

Project description:Identification of differentially expressed genes due to LBH589 treatment in aromatase inhibitor-resistant tumors

2025-01-24 | E-GEOD-47346 | ExpressionAtlas

E-TABM-142

Project description:Transcription profiling of wild type and loss-of-function mutants of Mla1 and Mla6 powdery mildew resistant allele barley plants

2015-12-04 | E-TABM-142 | ExpressionAtlas

Escherichia coli strain:K-12 MC4100, Tn10

Project description:Beta-thujaplicin resistant mutants

| PRJNA317940 | ENA

E-GEOD-19777

Project description:Antisense miRNA-221/222 (si221/222) and control inhibitor (GFP) treated fulvestrant-resistant breast cancer cells

2025-01-24 | E-GEOD-19777 | ExpressionAtlas

Whole genome sequencing of aureobasidin A resistant mutants in Candida albicans

Project description:We treated C. albicans reference strain SC5314 with 20ng/ml of aureobasidin A, and obtained two mutants which were resistant to aureobasidin A. Then we did whole genome sequencing of these two mutants.

2020-04-09 | E-MTAB-8942 | biostudies-arrayexpress

Project description:C. elegans DTT-resistant mutants

| PRJNA786771 | ENA